October 22, 2020
Home Posts tagged Business Wire (Page 3)
Business News

CarLotz, Inc., One of the Largest Privately-Held Used Vehicle Retail Disruptors with the Industry’s Only Consignment-to-Retail Sales Platform, to Become a Public Company

MIAMI & RICHMOND, Va.–(BUSINESS WIRE)–Acamar Partners Acquisition Corp. (Nasdaq: ACAM) (“Acamar Partners”), a publicly-traded special purpose acquisition company, and CarLotz, Inc. (“CarLotz” or the “Company”), one of the largest privately-held used vehicle retail disruptors with the industry’s only consignment-to-retail sales platform, announced today they
Business News

Amazon and small business J.L. Childress File Joint Lawsuit against Counterfeiters

SEATTLE–(BUSINESS WIRE)–Today, Amazon (NASDAQ: AMZN) and J.L. Childress unsealed a jointly filed lawsuit against 11 named individuals (collectively, the “defendants”) for counterfeiting J.L. Childress’ products, including travel bags for car seats and strollers. The defendants, by offering the infringing products for sale in Amazon’s store, violated Amazon’s
Business News

Concert Pharmaceuticals Announces Publication on Alopecia Areata Burden of Disease in Journal of Investigative Dermatology

LEXINGTON, Mass.–(BUSINESS WIRE)–Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that the Journal of Investigative Dermatology published results from a survey designed to understand the burden and everyday experience for patients living with moderate-to-severe alopecia areata. The survey was conducted by the National Alopecia Areata Foundation
Business News

Auto Insurance Claims Satisfaction Climbs to Record High as Carriers Refine Customer Experience During Pandemic, J.D. Power Finds

TROY, Mich.–(BUSINESS WIRE)–One silver lining to the COVID-19 pandemic: a 22% decline in frequency of auto insurance repairable claims has given insurers some breathing room to refine their customer experience and deliver higher touch and higher quality service during the claims process. According to the J.D. Power 2020 U.S. Auto Claims Satisfaction StudySM,
Business News

Asana BioSciences to Present Clinical Data on Oral ASN007, A Novel ERK1/2 Inhibitor, at the 32nd EORTC-NCI-AACR Symposium

LAWRENCEVILLE, N.J.–(BUSINESS WIRE)–Asana BioSciences, a clinical stage biopharmaceutical company, announced that ASN007 clinical data on safety, efficacy and pharmacokinetics in solid tumor patients will be presented at the 32nd EORTC-NCI-AACR Virtual Symposium on Molecular Targets and Cancer Therapeutics (ENA 2020) to be held on October 24-25, 2020. Details